Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
CHAD THERAPEUTICS INC (CTU) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/20/2009 8-K Quarterly results
08/08/2008 8-K/A Form 8-K/A -- Current report [amend]
08/04/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "Dormio Tech Division of CHAD Therapeutics Receives FDA Clearance To Market Its FloCHANNEL Sleep Diagnostic Device"
07/25/2008 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial ...
Docs: "CHAD Therapeutics Receives Letter From The American Stock Exchange Citing Non-Compliance With Certain Listing Requirements"
03/11/2008 8-K Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhi...
02/27/2008 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
02/20/2008 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
02/01/2008 8-K Regulation FD Disclosure, Financial Statements and Exhibits
01/04/2008 8-K Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregister...
08/03/2007 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
06/29/2007 8-K Quarterly results
Docs: "CHAD Therapeutics, Inc. Fourth Quarter and Fiscal 2007 Results"
12/12/2006 8-K/A Changes in Registrant.s Certifying Accountant, Financial Statements and Exhibits
11/29/2006 8-K Changes in Registrant.s Certifying Accountant, Financial Statements and Exhibits
08/11/2005 8-K Quarterly results
Docs: "CHAD Therapeutics Reports Fiscal 2006 First Quarter Financial Results CHATSWORTH, California, August 11, 2005 . . . CHAD Therapeutics, Inc. today announced operating results for the first quarter of fiscal 2006. “Continued rapid growth of sales of our oxygen conservers in international markets and higher sales of our TOTAL O 2 7 home oxygen filling system largely offset a reduction in domestic conserver sales in this year's first quarter compared to the first quarter of fiscal 2005,” said Earl L. Yager, President and Chief Executive Officer. “Our discussions regarding potential distribution options for our TOTAL O 2 system and our sleep disorder products are continuing. We hope to make decisions this summer regarding distribution for both of these product families. Regarding TOTAL O 2..."
06/24/2005 8-K Results of Operations and Financial Condition
03/08/2005 8-K/A Quarterly results
Docs: "CHAD Therapeutics Third Quarter Net Income Advanced 21% On 23% Revenue Gain"
03/08/2005 8-K/A Quarterly results
Docs: "CHAD Therapeutics Second Quarter Net Earnings Tripled On 19% Revenue Gain"
02/09/2005 8-K Quarterly results
11/05/2004 8-K Quarterly results
09/10/2004 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
02/13/2004 8-K Results of Operations and Financial Condition, Regulation FD Disclosure
05/23/2003 8-K Regulation FD Disclosure
04/22/2003 8-K Regulation FD Disclosure
07/09/1999 8-K Resignations of registrant's directors
04/30/1997 8-K Other events, Financial statements and exhibits

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy